AN2 Therapeutics, Inc. (ANTX) — EPS (Diluted)
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.16 | +32.6% |
| 2024 | $-1.72 | +37.2% |
| 2023 | $-2.74 | +1.8% |
| 2022 | $-2.79 | +73.8% |
| 2021 | $-10.64 | — |
| Fiscal Year | EPS (Diluted) | Change YoY |
|---|---|---|
| 2025 | $-1.16 | +32.6% |
| 2024 | $-1.72 | +37.2% |
| 2023 | $-2.74 | +1.8% |
| 2022 | $-2.79 | +73.8% |
| 2021 | $-10.64 | — |